Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-07-28 17:16:17
Reporting Period:
Filing Date:
Accepted Time:
2017-07-28 17:16:17
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
811641 Immucell Corp ICCC In Vitro & In Vivo Diagnostic Substances (2835) 010382980
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1582758 L. Brian Pessin 310 East 75Th Street
Apt. 2A
New York NY 10021
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-27 30,000 $5.25 70,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. The Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock.